2-42767878-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_012205.3(HAAO):c.681C>T(p.Asp227Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00228 in 1,614,010 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 7 hom. )
Consequence
HAAO
NM_012205.3 synonymous
NM_012205.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.514
Genes affected
HAAO (HGNC:4796): (3-hydroxyanthranilate 3,4-dioxygenase) 3-Hydroxyanthranilate 3,4-dioxygenase is a monomeric cytosolic protein belonging to the family of intramolecular dioxygenases containing nonheme ferrous iron. It is widely distributed in peripheral organs, such as liver and kidney, and is also present in low amounts in the central nervous system. HAAO catalyzes the synthesis of quinolinic acid (QUIN) from 3-hydroxyanthranilic acid. QUIN is an excitotoxin whose toxicity is mediated by its ability to activate glutamate N-methyl-D-aspartate receptors. Increased cerebral levels of QUIN may participate in the pathogenesis of neurologic and inflammatory disorders. HAAO has been suggested to play a role in disorders associated with altered tissue levels of QUIN. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00165 (252/152374) while in subpopulation NFE AF= 0.00288 (196/68032). AF 95% confidence interval is 0.00255. There are 0 homozygotes in gnomad4. There are 96 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HAAO | NM_012205.3 | c.681C>T | p.Asp227Asp | synonymous_variant | 8/10 | ENST00000294973.11 | NP_036337.2 | |
HAAO | XM_011532729.4 | c.591C>T | p.Asp197Asp | synonymous_variant | 7/9 | XP_011531031.1 | ||
HAAO | XM_011532730.4 | c.579C>T | p.Asp193Asp | synonymous_variant | 9/11 | XP_011531032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HAAO | ENST00000294973.11 | c.681C>T | p.Asp227Asp | synonymous_variant | 8/10 | 1 | NM_012205.3 | ENSP00000294973.6 | ||
HAAO | ENST00000402698.6 | n.1025C>T | non_coding_transcript_exon_variant | 7/9 | 5 | |||||
HAAO | ENST00000404451.7 | n.440C>T | non_coding_transcript_exon_variant | 6/6 | 3 | |||||
HAAO | ENST00000406007.6 | n.232C>T | non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00166 AC: 252AN: 152256Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
252
AN:
152256
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00154 AC: 386AN: 251360Hom.: 0 AF XY: 0.00149 AC XY: 202AN XY: 135850
GnomAD3 exomes
AF:
AC:
386
AN:
251360
Hom.:
AF XY:
AC XY:
202
AN XY:
135850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00234 AC: 3423AN: 1461636Hom.: 7 Cov.: 31 AF XY: 0.00233 AC XY: 1692AN XY: 727130
GnomAD4 exome
AF:
AC:
3423
AN:
1461636
Hom.:
Cov.:
31
AF XY:
AC XY:
1692
AN XY:
727130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00165 AC: 252AN: 152374Hom.: 0 Cov.: 33 AF XY: 0.00129 AC XY: 96AN XY: 74518
GnomAD4 genome
AF:
AC:
252
AN:
152374
Hom.:
Cov.:
33
AF XY:
AC XY:
96
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 08, 2022 | Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -18
Find out detailed SpliceAI scores and Pangolin per-transcript scores at